← brief for 2026-10-13 · Slowing decline

Real-World Effects of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Gout Outcomes and Metabolic Profiles

Article C Peer reviewed Observational

Key takeaways

This study looked at 64 people with gout. It compared different diabetes drugs over two years. It shows a link between these drugs and gout outcomes, but it is not proof of cause.

Who did this work

Merna Abdelsalhen (Tawam Hospital) · Abdulfatah Hanoun (Tawam Hospital) · Shamma Alshamsi (Tawam Hospital) · Muhammad Jawad Hashim (Al Ain Hospital) · Shamma Ahmad Al Nokhatha (United Arab Emirates University)

Source

Article · OpenAlex, CKD works · 2026-10-12
https://doi.org/10.1055/s-0046-1827830